George Elston Eye Point Pharmaceuticals, Inc. (EYPT) insider trading activity

EYPT Quotes by TradingView

George Elston is Chief Financial Officer of EyePoint Pharmaceuticals, Inc.. Currently has a direct ownership of 47,480 shares of EYPT, which is worth approximately $341,856. The most recent transaction as insider was on May 25, 2024, when has been sold 3,627 shares (Common Stock) at a price of $11.16 per share, resulting in proceeds of $40,477. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.5K
0% 3M change
105.4% 12M change
Total Value Held $341,856

George Elston Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 25 2024
SELL
Payment of exercise price or tax liability
$40,477 $11.16 p/Share
3,627 Reduced 7.1%
47,480 Common Stock
May 25 2024
BUY
Exercise of conversion of derivative security
-
7,500 Added 12.8%
51,107 Common Stock
Feb 09 2024
SELL
Payment of exercise price or tax liability
$91,929 $28.8 p/Share
3,192 Reduced 6.82%
43,607 Common Stock
Feb 09 2024
BUY
Exercise of conversion of derivative security
-
10,800 Added 18.75%
46,799 Common Stock
Jan 06 2024
SELL
Payment of exercise price or tax liability
$100,184 $20.4 p/Share
4,911 Reduced 12.21%
35,308 Common Stock
Jan 06 2024
BUY
Exercise of conversion of derivative security
-
15,285 Added 27.54%
40,219 Common Stock
Feb 09 2023
BUY
Exercise of conversion of derivative security
-
10,800 Added 31.84%
23,116 Common Stock
Feb 09 2022
SELL
Payment of exercise price or tax liability
$17,434 $10.13 p/Share
1,721 Reduced 15.2%
9,602 Common Stock
Feb 09 2022
BUY
Exercise of conversion of derivative security
-
4,966 Added 30.49%
11,323 Common Stock
GE

George Elston

Chief Financial Officer
Watertown, MA

Track Institutional and Insider Activities on EYPT

Follow EyePoint Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EYPT shares.

Notify only if

Insider Trading

Get notified when an Eye Point Pharmaceuticals, Inc. insider buys or sells EYPT shares.

Notify only if

News

Receive news related to EyePoint Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EYPT